POSTER: AML-530 Sequential Salvage Chemotherapy and Lintuzumab-Ac225 in Relapsed/Refractory AML Results in Deep Responses and Prolonged Survival in Adverse Risk Acute Myeloid Leukemia (AML) and in AML Patients that Received Prior Venetoclax Therapy

Clinical Lymphoma, Myeloma & Leukemia(2023)

引用 0|浏览6
暂无评分
关键词
AML,radioimmunotherapy,relapsed AML,venetoclax,Phase I
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要